The changes were made based on a request from Ministry of Health, Labor and Welfare for development of new dosages of Pasetocin.
Pasetocin is a broad spectrum antibiotic that, when administered in higher doses, promises to be effective against various bacterial strains.
The company claims as such, having also considered factors such as the approval status of the medicine overseas, we have filed application regarding a change in the maximum daily applied dose with respect to indicated strains and indications that have already been approved.